The LYX Foundation is an institution committed to promoting the development and the scientific knowledge of Urology, Andrology and Men´s Health through teaching and researching activities.
Located in the centre of Madrid, it has a team of medical experts who work jointly towards the achievement of academic excellence in specific areas.
Eugenio Cerezo López, MD, PhD, is an Internal Medicine and Gastroenterology specialist, expert in ultrasound.
Dr. Cerezo achieved his MD degree, from Universidad Autónoma of Madrid, Spain.
He was certified as Internal Medicine and Gastroenterologist specialist and obtained his Ph.D “Cum Laude” from UAM in 1992 on the dissertation “Scrotal Ultrasound"
Dr. Cerezo has a profound commitment to research. His interests are broad and include baseline penile doppler ultrasound and after vasoactive testing for the study of erectile dysfunction, Peyronie’s disease and other male sexual dysfunctions, as well as scrotal ultrasound, other urological ultrasound, thyroid or muskuloeskeletal US, small vessel Doppler and abdominal US elastography.
He is the author of more than 20 publications in radiology, gastroenterology and internal medicine as well as medical textbooks. He served as honorary professor of the Faculty of Medicine of the “Universidad Autónoma de Madrid” until 1998 and served as staff of the Gastroenterology Department of the “Hospital Universitario La Paz” until 1998. Since 2006 he serves as Head of the Ultrasound Unit of the “Ecografias America” Group in Madrid and Head of the US Unit of the Clinica DKF in Madrid. He served also as US expert in Lyx Institute of Urology.
Eugenio Cerezo López, MD, PhD, is an Internal Medicine and Gastroenterology specialist, expert in ultrasound.
Dr. Cerezo achieved his MD degree, from Universidad Autónoma of Madrid, Spain.
He was certified as Internal Medicine and Gastroenterologist specialist and obtained his Ph.D “Cum Laude” from UAM in 1992 on the dissertation “Scrotal Ultrasound"
Dr. Cerezo has a profound commitment to research. His interests are broad and include baseline penile doppler ultrasound and after vasoactive testing for the study of erectile dysfunction, Peyronie’s disease and other male sexual dysfunctions, as well as scrotal ultrasound, other urological ultrasound, thyroid or muskuloeskeletal US, small vessel Doppler and abdominal US elastography.
He is the author of more than 20 publications in radiology, gastroenterology and internal medicine as well as medical textbooks. He served as honorary professor of the Faculty of Medicine of the “Universidad Autónoma de Madrid” until 1998 and served as staff of the Gastroenterology Department of the “Hospital Universitario La Paz” until 1998. Since 2006 he serves as Head of the Ultrasound Unit of the “Ecografias America” Group in Madrid and Head of the US Unit of the Clinica DKF in Madrid. He served also as US expert in Lyx Institute of Urology.
Fernando J. Bianco, MD is a faculty at Nova University, Urology Specialists and Lyx Health of Florida of Urological Excellence, Investigator in-chief for the Urological Research Network, he is an Innovator Urological Oncologist and Robotic Surgeon who has conducted more than 12 randomized clinical trials - committed to the best care options for his patients.
Dr Bianco serves as principal investigator for the Fusion Image - MRI/US -Guided Cryotherapy of the Prostate Clinical Trial - NCT02381990 – an innovative disruptive technology of the FocalyxTx paradigm. In addition, Dr. Bianco has served as a lead scientist involved in the PRO-IMPACT trial that evaluates the molecular profiles of prostate cancers and its chances of disseminating in the short term. This represents an important effort supported by the Society of Urological Oncology Clinical Trials Consortium NCT02080689. Other important contributions by Dr. Fernando J. Bianco include: characterization of PSA response to androgen deprivation therapies after surgery; association between testosterone levels and prostate cancer and the impact of surgeon’s experience in prostate cancer survival and morbidity outcomes.
Throughout his career, Dr Bianco has held prestigious faculty positions. Upon completion of his Urological Oncology and Laparoscopic studies at Memorial Sloan-Kettering Cancer Center in the city of New York - where he was a Scholar for the American Urological Association Care Foundation (2003-2005); and the Koch and Albittron Foundations Scholar for Prostate Cancer (2005-2006) - he moved to Washington, DC to serve as Chief of Urology Oncology at the Department of Urology of The George Washington University.
Dr Bianco relocated to South Florida in 2008, serving as Associate Professor of Columbia University in the city of New York and as Founder and Director of the Columbia University Division of Urology as well as Director of Robotic Surgery at Mt Sinai Hospital in Miami Beach. By 2011 he Co-founded the Robotic Surgery program at Doctors Hospital (Coral Gables, FL). His work has been highlighted by the urological community: he was awarded by the American Urological Association, Society of Urological Oncology and American Society of Clinical Oncology. He serves on the review panel and editorial board of numerous publications, including the Journal of Urology, Urology Oncology, Journal of Clinical Oncology, Urology, Cancer, Lancet Oncology and European Urology – where he served as member of the editorial board-at large.
His more than 100 publications, vast experience and concern of the deleterious effect in quality of life of patients after prostate cancer treatment, leaded him to serve as a central stone of focal therapy for prostate cancer and the innovative disruptive technology of the Focalyx paradigm.
Ernesto Castillo (MD) radiologist is currently working at Instituto Radiológico Castillo in Madrid, as MRI specialist in radiology. With special development in multiparametric MRI, he is an experienced radiologist in prostate mp MRI at diagnosis and at follow-up schemes including both focal therapy ablative treatments and radical treatments. He has been working in the multidisciplinary team of Focalyx as referral radiologist of fusion biopsies and focal therapy planning.
Healthcare Industry
